Posted in | eBooks

Driving innovation in Korean drug development

South Korea is rapidly becoming the epicenter of targeted treatments innovation.

To fulfill the increasing demand for more secure, more effective drugs with wider therapeutic windows that can enhance the standard of care treatments and address an unmet medical need, the World Advanced Therapeutics Summit South Korea brings together two of the most exciting modalities under one roof, providing unparalleled opportunities for idea exchange, collaboration, and networking.

This is an opportunity to gain full coverage of Korea’s fastest-growing R&D sectors by attending two co-located events: the flagship 2nd World RNA-Based Therapeutics & Vaccines Summit South Korea and the new World Cell & Gene Therapy Summit South Korea.

With an audience that includes C-level executives and VP/Directors, the summit brings together over 160 renowned experts to drive innovation, distinguish your pipeline, and speed drug development.

About 2nd World RNA-Based Therapeutics & Vaccines Summit South Korea

South Korea is fast becoming the epicentre of targeted therapeutics innovation. To meet the growing demand for safer, more effective drugs with broader therapeutic windows that can improve on standard of care treatments and meet an unmet medical need, the World Advanced Therapeutics Summit South Korea brings together two of the hottest modalities under one roof to create unparalleled opportunities for idea exchange, collaboration, and networking.

Taking place as two co-located events with the flagship 2nd World RNA-Based Therapeutics & Vaccines Summit South Korea and the brand-new World Cell & Gene Therapy Summit South Korea, this is the opportunity to gain comprehensive coverage of the fastest-growing R&D areas in Korea.

With an audience ranging from C-level execs and VP/Directors, the summit joins together over 160 leading experts to drive innovation, differentiate your pipeline and accelerate drug development.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.